Replimune

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.

CEO

Sushil Patel

CEOSushil Patel

Employees

479

Employees479

Headquarters

Woburn, Massachusetts

HeadquartersWoburn, Massachusetts

Founded

2015

Founded2015

Employees

479

Employees479

REPL Key Statistics

Market cap

351.25M

Market cap351.25M

Price-Earnings ratio

-1.33

Price-Earnings ratio-1.33

Dividend yield

—

Dividend yield—

Average volume

2.94M

Average volume2.94M

High today

$4.75

High today$4.75

Low today

$4.49

Low today$4.49

Open price

$4.67

Open price$4.67

Volume

1.65M

Volume1.65M

52 Week high

$17.00

52 Week high$17.00

52 Week low

$2.68

52 Week low$2.68

Analyst ratings

56%

of 9 ratings

Buy

22.2%

Hold

55.6%

Sell

22.2%

People also own

Based on the portfolios of people who own REPL. This list is generated using Robinhood data, and it’s not a recommendation.